110398 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
SIMULTANEOUS DETECTION OF ANTIGENS AND ANTIGEN SPECIFIC ANTIBODIES IN A GUINEA PIG MODEL SYSTEM
#2Engineered Antimicrobial Peptides and Usage Thereof
#3COMPOSITIONS AND METHODS FOR DETECTING HIV LATENCY, TREATING HIV INFECTION, AND REVERSING HIV LATENCY
#4Immune cells with DNMT3A gene modifications and methods related thereto
#5HIV antibody derivatives with dual antiviral and immunomodulatory activities from CD4 and GP41
#6Cell-penetrating compstatin analogs and uses thereof
#7FRATAXIN-SENSITIVE MARKERS FOR DETERMINING EFFECTIVENESS OF FRATAXIN REPLACEMENT THERAPY
#8Helix-grafted proteins as inhibitors of disease-relevant protein-protein interactions
#9Use of a HIV derived accessory protein for the reactivation of latent HIV
#10MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF
#11Cell-penetrating compstatin analogs and uses thereof
#12Peptides having effects of preventing or treating central nervous system diseases and pharmaceutical compositions for preventing or treating central nervous system diseases containing same as active ingredient
#13Immune cells with DNMT3A gene modifications and methods related thereto
#14Methods for Optimizing CATS Immunotherapeutics into Humanized Derivatives with Reduced Autoreactivity, Reduced Toxicity and Enhanced Long-Term Efficacy
#15DAGRS: directed antigonists to cancer cell growth signals
#16Compositions and Methods for Treating an Immunodeficiency Virus Infection
#17Autologous HIV-1 proteins for the treatment of latent HIV-1 infection
#18Modular antigen transportation molecules and uses thereof in animals
#19Use of a HIV derived accessory protein for the reactivation of latent HIV
#20Therapeutic applications of Smad7
#21Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#22Vaccine and therapeutic delivery system
#23Methods of treating obesity by administering a TAT peptide
#24DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#25Cell-penetrating compstatin analogs and uses thereof
#26Autologous HIV-1 proteins for the treatment of latent HIV-1 infection
#27Helix-grafted proteins as inhibitors of disease-relevant protein-protein interactions
#28Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
#29Mitochondrial proteins constructs and uses thereof
#30Expression of HIV inhibitors by Mesenchymal stem cells
#31Vaccine and therapeutic delivery system
#32Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#33Therapeutic applications of SMAD7
#34PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES
#35Vector for the selective silencing of a gene in astrocytes
#36C-terminal fragments of glucagon-like peptide-1 (GLP-1)
#37CELLULAR APOBEC3 PROTEINS AND MODULATORS THEREOF FOR REGULATING DNA REPAIR PROCESSES AND TREATING PROLIFERATIVE DISEASES
#38Compositions for promoting HIV-1 virolysis and methods using same
#39Tubulin-interacting protein, caltubin, promotes axonal growth
#40Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
#41Antigenic polypeptides comprising pre-hairpin intermediate conformations of HIV-1 GP41
#42Vaccine and therapeutic delivery system
#43Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
#44Compositions and methods for treating cancer by inhibiting the secretion of microparticles
#45DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#46Methods and compositions for inhibiting viral entry into cells
#47C-terminal fragments of glucagon-like peptide-1 (GLP-1)
#48Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
#49Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#50Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#51Virus derived antimicrobial peptides
#52Chimeric vector and preparation method and use thereof